miR‐137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6
暂无分享,去创建一个
Hao Li | Yuefeng Li | Xiaolan Zhu | Yuefeng Li | Xiaolan Zhu | Huiling Shen | Hao Li | L. Long | L. Hui | Wenlin Xu | Huiling Shen | Lulu Long | Lulu Hui | Wenlin Xu
[1] J. Inazawa,et al. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. , 2008, Cancer research.
[2] A. Kong,et al. Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice. , 2006, Cancer research.
[3] Olga Kovalchuk,et al. Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin , 2008, Molecular Cancer Therapeutics.
[4] A. Jemal,et al. Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.
[5] P. Hinds,et al. From Cell Cycle to Differentiation: An Expanding Role for Cdk6 , 2006, Cell cycle.
[6] X. Chen,et al. miR‐137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells , 2011, International journal of cancer.
[7] Axel Benner,et al. Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] F. Slack,et al. The let-7 microRNA reduces tumor growth in mouse models of lung cancer , 2008, Cell cycle.
[9] T. Jiang,et al. miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2. , 2012, European journal of cancer.
[10] Philippe P Roux,et al. Raf-MEK-Erk Cascade in Anoikis Is Controlled by Rac1 and Cdc42 via Akt , 2001, Molecular and Cellular Biology.
[11] Yi Shen,et al. Growth and motility inhibition of breast cancer cells by epidermal growth factor receptor degradation is correlated with inactivation of Cdc42. , 2006, Cancer research.
[12] Yu-Dong Cai,et al. Dysfunctions Associated with Methylation, MicroRNA Expression and Gene Expression in Lung Cancer , 2012, PloS one.
[13] D. Hu,et al. Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma. , 2011, Investigative ophthalmology & visual science.
[14] R. A. Baker,et al. Cell Cycle Activation in Postmitotic Neurons is Essential for DNA Repair , 2007, Cell cycle.
[15] S. Dacic,et al. miRNA expression profiling of lung adenocarcinomas: correlation with mutational status , 2010, Modern Pathology.
[16] F. He,et al. MiR-137 Targets Estrogen-Related Receptor Alpha and Impairs the Proliferative and Migratory Capacity of Breast Cancer Cells , 2012, PloS one.
[17] Scott M Langevin,et al. MicroRNA-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass index. , 2010, Carcinogenesis.
[18] S. Robinson,et al. MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines. , 2008, Cancer research.
[19] Hao Li,et al. miR-181a sensitizes a multidrug-resistant leukemia cell line K562/A02 to daunorubicin by targeting BCL-2. , 2012, Acta biochimica et biophysica Sinica.
[20] D. Norris,et al. MicroRNA-137 Targets Carboxyl-terminal Binding Protein 1 in Melanoma Cell Lines , 2011, International journal of biological sciences.
[21] M. Svoboda,et al. Micro-RNAs miR125b and miR137 are frequently upregulated in response to capecitabine chemoradiotherapy of rectal cancer. , 2008, International journal of oncology.
[22] E. Knudsen,et al. Cyclin-dependent kinase 4/6 activity is a critical determinant of pre-replication complex assembly , 2008, Oncogene.
[23] Poshen B. Chen,et al. N-α-acetyltransferase 10 protein suppresses cancer cell metastasis by binding PIX proteins and inhibiting Cdc42/Rac1 activity. , 2011, Cancer cell.
[24] J. Rehwinkel,et al. MicroRNAs silence gene expression by repressing protein expression and/or by promoting mRNA decay. , 2006, Cold Spring Harbor symposia on quantitative biology.
[25] P. Gaffney,et al. Genes associated with early development, apoptosis and cell cycle regulation define a gene expression profile of adenoid cystic carcinoma. , 2006, Oral oncology.
[26] R. Stone,et al. MicroRNA‐137 promoter methylation is associated with poorer overall survival in patients with squamous cell carcinoma of the head and neck , 2011, Cancer.
[27] N M Hjelm,et al. Expression of p19INK4d, CDK4, CDK6 in glioblastoma multiforme. , 2000, British journal of neurosurgery.
[28] C. Welsh. Rho GTPases as Key Transducers of Proliferative Signals in G1 Cell Cycle Regulation , 2004, Breast Cancer Research and Treatment.
[29] Y. Shiratori,et al. Activation of cyclin D1-related kinase in human lung adenocarcinoma , 1999, British Journal of Cancer.
[30] Yunqing Li,et al. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. , 2009, Cancer research.
[31] C. Boland,et al. Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis. , 2010, Cancer research.
[32] J. Qu,et al. MicroRNA-1/206 Targets c-Met and Inhibits Rhabdomyosarcoma Development* , 2009, The Journal of Biological Chemistry.
[33] Susan J. Clark,et al. MicroRNA Alterations and Associated Aberrant DNA Methylation Patterns across Multiple Sample Types in Oral Squamous Cell Carcinoma , 2011, PloS one.
[34] E. Wang,et al. Overexpression of small GTPases directly correlates with expression of δ‐catenin and their coexpression predicts a poor clinical outcome in nonsmall cell lung cancer , 2013, Molecular carcinogenesis.
[35] Xiaolan Zhu,et al. miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A. , 2012, Acta Biochimica et Biophysica Sinica.
[36] Q. Fan,et al. miR-137 Is Frequently Down-Regulated in Gastric Cancer and Is a Negative Regulator of Cdc42 , 2011, Digestive Diseases and Sciences.
[37] Hongbing Shen,et al. Potentially functional polymorphisms in cell cycle genes and the survival of non-small cell lung cancer in a Chinese population. , 2011, Lung cancer.
[38] N. Pattabiraman,et al. Selectivity and potency of cyclin-dependent kinase inhibitors , 2006, The AAPS Journal.
[39] Claudia Petritsch,et al. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells , 2008 .